Results for
""Phenindione""[mesh_terms]

Immunoallergic adverse effects of fluindione.

Prescrire international 2011;19(110):255-6

Aspirin--anticoagulant combination in patients with non valvular atrial fibrillation commentary on the FFAACS study results.

Philippe P Lechat

Cardiac electrophysiology review 2004;7(4):372-3

Effect of Body Weight on Dose of Vitamin K Antagonists.

Timothy H Self, Jessica L Wallace, Sami Sakaan, Christopher W Sands

Southern medical journal 2016;108(10):637-43

Potentiation of fluindione or warfarin by dexamethasone in multiple myeloma and AL amyloidosis.

Jérémie Sellam, Nathalie Costedoat-Chalumeau, Zahir Amoura, Guy Aymard, Sylvain Choquet, Salim Trad, Bénédicte Lebrun Vignes, Jean-Sébastien Hulot, Francis Berenbaum, Philippe Lechat, Patrice Cacoub, Annick Ankri, Xavier Mariette, Véronique Leblond, Jean-Charles Piette

Joint bone spine 2007;74(5):446-52

Effect of diseases on response to vitamin K antagonists.

Timothy H Self, Ryan E Owens, Sami A Sakaan, Jessica L Wallace, Christopher W Sands, Amanda Howard-Thompson

Current medical research and opinion 2016;32(4):613-20

Vitamin K antagonists and cognitive impairment: results from a cross-sectional pilot study among geriatric patients.

Cédric Annweiler, Guylaine Ferland, Pascale Barberger-Gateau, Antoine Brangier, Yves Rolland, Olivier Beauchet

The journals of gerontology. Series A, Biological sciences and medical sciences 2015;70(1):97-101

Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.

José L Zamorano, Irene Lang, Holger Thiele, Peter Nordbeck, Raul Moreno, Luis Nombela-Franco, Diego López-Otero, Roxana Mehran, Helge Möllmann, Christian Hengstenberg, Martin Unverdorben, Nicolas M Van Mieghem, Fayaz Shawl, Hyo-Soo Kim, George D Dangas, Shigeru Saito, Roland Veltkamp, Marco Valgimigli, Cathy Chen, Hans Lanz, Petra Laeis, Anil Duggal, Usman Baber, Richard Anderson, Thomas Pilgrim, Piera Capranzano, Patrick Ohlmann, Josep Rodés-Cabau, Eric Boersma, James Jin, Pascal Vranckx, Felix Meincke, Rainer Hambrecht, Kentaro Hayashida, Yusuke Watanabe, Masanori Yamamoto

The New England journal of medicine 2021;385(23):2150-2160

Unexpected Problems of Antithrombotic Therapy with An Unusual Side Effect of Vitamin K Antagonists after Mitral Valve Replacement.

Olivier Morel, Patrick Ohlmann, Antje Reydel, Marion Kibler, Annie Trinh, Laurence Jesel, Nathan Messas, Benjamin Marchandot

The Journal of heart valve disease 2018;26(3):309-313

Risk factors associated with a thrombotic or bleeding event in patients treated with vitamin K antagonists.

J Béné, A-E Dubart, C Senis, M Auffret, J Caron, S Gautier

Journal des maladies vasculaires 2016;39(4):248-55

A pharmacokinetic-pharmacodynamic model for predicting the impact of CYP2C9 and VKORC1 polymorphisms on fluindione and acenocoumarol during induction therapy.

Céline Verstuyft, Xavier Delavenne, Alexandra Rousseau, Annie Robert, Michel Tod, Bertrand Diquet, Martine Lebot, Patrice Jaillon, Laurent Becquemont

Clinical pharmacokinetics 2012;51(1):41-53

Dabigatran versus vitamin k antagonist: an observational across-cohort comparison in acute coronary syndrome patients with atrial fibrillation.

F Paganelli, L Camoin-Jau, L Bonello, M Laine, N Resseguier, M Gaubert

Journal of thrombosis and haemostasis : JTH 2019;16(3):465-473